Quantcast
AstraZeneca antibody cocktail works against Omicron in study – Metro US

AstraZeneca antibody cocktail works against Omicron in study

FILE PHOTO: Exterior photo of the North America headquarters of
FILE PHOTO: Exterior photo of the North America headquarters of AstraZeneca

(Reuters) – AstraZeneca said on Thursday a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron coronavirus variant, showing promise for wider use of the therapy.

The study was conducted by independent investigators of the U.S. Food and Drug Administration, the company said, adding that more analyses of Evusheld against Omicron are being conducted by AstraZeneca and third-parties, with data expected “very soon”.

(Reporting by Pushkala Aripaka in Bengaluru; Editing by Anil D’Silva)

More from our Sister Sites